Similar to the results obtained for RAW264.7 cells, treatment of primary osteoclast precursor cells with RANKL in combination with the lower concentration of tumor cell-derived exosomes (10 ng/103 seeded cells) did not result in any significant effect on osteoclast formation (Fig 4B). This evidence concerns the gene TNFSF11 and neoplasm.